Stent News and Research

RSS

A stent is a small mesh tube that’s used to treat narrowed or weakened arteries in the body.

You may have a stent placed in an artery as part of a procedure called angioplasty (AN-jee-oh-plas-tee). Angioplasty can restore blood flow through narrowed or blocked arteries. Stents help prevent arteries from becoming narrowed or blocked again in the months or years after treatment with angioplasty. You may also have a stent placed in a weakened artery to improve blood flow and to help prevent the artery from bursting.

Stents are usually made of metal mesh, but sometimes they’re made of fabric. Fabric stents, also called stent grafts, are used in larger arteries. Some stents are coated with medicines that are slowly and continuously released into the artery. These medicines help prevent the artery from becoming blocked again.

OpEds: Ryan on 'welfare state'; Wisconsin health care; Facing AIDS; Penn. safety net

Government health programs can help fulfill the mission of health security, but the current structures of Medicare, Medicaid - and now Obamacare - rely on a faulty architecture that puts the federal government in charge on health care decision-making.

13 Dec 2010

Process of activating helicopter EMS delays treatment for heart attacks beyond recommended times

Helicopter emergency medical services can be a life saver for patients needing immediate care. But, according to a University of Cincinnati study, the process of activating them often delays treatment beyond recommended times.

10 Dec 2010

STENTYS initiates international APPOSITION III self-apposing stent study in AMI patients

STENTYS S.A., which develops innovative stents to treat Acute Myocardial Infarction (AMI), announced today that it has begun the international APPOSITION III study of its self-apposing stent, with 50 patients already enrolled out of a total of 500. The trial primary endpoint is Major Adverse Cardiac Events at 12 months post-procedure.

10 Dec 2010

Everolimus plus tamoxifen delays disease progression in HR+/HER2- metastatic breast cancer

A new study shows that the addition of everolimus (Afinitor® tablets) to the hormonal therapy tamoxifen in patients with hormone-receptor positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer who have been previously treated with an aromatase inhibitor (AI) delays disease progression compared to tamoxifen alone. These results were presented today at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium in San Antonio, Texas.

10 Dec 2010

Children's Hospitals and Clinics of Minnesota installs Toshiba's Infinix CC-i system and MAQUET OR table

To advance its ability to provide patients with the highest quality of care and increase the collaboration between pediatric surgical and interventional doctors, Children's Hospitals and Clinics of Minnesota recently installed Toshiba America Medical System's InfinixTM CC-i cardiac imaging system and the MAQUET OR table to form its new hybrid operating room (OR) suite.

8 Dec 2010

ART's stent superior than other bioresorbable stents

Arterial Remodeling Technologies disclosed today new data related to its bioresorbable stent platform—additional data that further validates the Company's innovative approach to simultaneously balance biocompatibility, biomechanics and bioresorption within a bioresorbable PLA (polylactic acid) stent.

8 Dec 2010

Sheathless transradial intervention highly successful in treating complex lesions

Cardiologists from the Mayo Clinic performed sheathless transradial percutaneous coronary intervention (PCI) to remedy complex lesions, achieving a 90% success rate with no radial complications. Standard guiding catheters were used during the procedure. Details of this novel approach—overcoming the last hurdle to greater adoption of transradial PCI in the U.S.—are published in the December issue of Catheterization and Cardiovascular Intervention, the official journal of The Society for Cardiovascular Angiography and Interventions.

7 Dec 2010

Cardiologists achieve 90% success rate in sheathless transradial PCI to remedy complex lesions

7 Dec 2010

Report: Baltimore cardiologist inserted 'medically unnecessary' stents

Abbott Laboratories, a $30 billion-a-year, Chicago-based pharmaceutical firm, ranked [Dr. Mark] Midei among its top-volume doctors in the Northeast and made plying him with research money and 'VIP trips' part of its business plan in late 2008 — about the time Midei's usage of Abbott-brand stents soared, the report said.

7 Dec 2010

Cardiologist provided unnecessary stent implants: investigation

In a new investigation a Senate Finance Committee has found that a former cardiologist, Mark Midei at Towson, Md.-based St. Joseph Medical Center performed 585 medically unnecessary stent implants, costing Medicare and private insurers a combined $6.6 million in fraudulent reimbursement fees. These stents are special medicated or wire tubes that are placed inside coronary arteries of the heart to prevent them from collapsing or clogging up which may lead to a hear attack.

6 Dec 2010

FDA approves IDE application to initiate Tryton Side Branch Stent System for coronary artery disease

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced U.S. Food and Drug Administration (FDA) conditional approval for an Investigational Device Exemption (IDE) application to initiate the pivotal trial to evaluate the Tryton Side Branch Stent System for the treatment of coronary artery disease.

2 Dec 2010

Cordis to distribute OSTIAL PRO Stent Positioning System worldwide

Cordis Corporation has entered into a distribution agreement with Ostial Solutions for the worldwide distribution of the OSTIAL PRO Stent Positioning System™. The OSTIAL PRO™ is the world's first and only aorto-ostial stent positioning system for coronary and peripheral applications. The OSTIAL PRO™ is intended to optimize the treatment of patients who require a stent implantation for treatment for aorto-ostial blockages.

30 Nov 2010

Interventional Radiology physician utilizes SUPERA VERITAS system to treat biliary stricture

IDEV Technologies, Incorporated, an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced the first procedure in the United States utilizing the SUPERA VERITAS Transhepatic Biliary System, which was recently cleared to market by the U.S. Food and Drug Administration.

30 Nov 2010

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

Micell Technologies,™ Inc. today announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries), a first-in-human clinical trial of the company's investigational MiStent™ Drug Eluting Coronary Stent System (MiStent DES).

29 Nov 2010

Medtronic's implantable device delivers positive results for abdominal aortic aneurysms treatment

An implantable medical device used in the minimally invasive treatment of abdominal aortic aneurysms, the Endurant Stent Graft System from Medtronic, Inc., delivered strong results through one year of patient follow-up in the company's U.S. pivotal study, according to clinical data presented at VEITHsymposium.

20 Nov 2010

Boston Scientific signs definitive agreement to acquire Sadra Medical

Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which Boston Scientific will acquire Sadra Medical, Inc., a development-stage company in Los Gatos, California. Sadra is developing the first fully repositionable device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis.

20 Nov 2010

Medtronic's Valiant Stent System effective for thoracic aortic aneurysms treatment

An implantable medical device used in the minimally invasive treatment of thoracic aortic aneurysms, the Valiant Thoracic Stent Graft System from Medtronic, Inc., delivered strong results through 30 days of patient follow-up in the company's U.S. pivotal study, according to clinical data presented at VEITHsymposium.

19 Nov 2010

GRAVITAS Trial finds high dose of clopidogrel does not reduce risk of ischemic events

Accumetrics, Inc., developer and marketer of the VerifyNow System, today announced that the GRAVITAS (Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety) Trial found that in patients with high residual platelet reactivity, doubling the maintenance dose of clopidogrel did not reduce the risk of further ischemic events after percutaneous coronary intervention (PCI).

19 Nov 2010

NTU to develop Five Peaks of Excellence under 5-year strategic plan

Nanyang Technological University (NTU) today unveiled NTU 2015, a five-year strategic plan that maps out how the university will become a great global university by 2015. Under this blueprint, NTU will build on its current strengths and heritage to make its mark globally in sustainability, healthcare, new media, the best of the East and West, and innovation.

18 Nov 2010

ESWL should be first choice for removing smaller kidney stones in distal ureter

Different techniques should be used to remove single stones that have become lodged in the distal ureter after being expelled by the kidney, depending on whether they are under or above one centimetre, according to the December issue of BJUI.

18 Nov 2010

Stent News and Research

Further Reading

OpEds: Ryan on 'welfare state'; Wisconsin health care; Facing AIDS; Penn. safety net

Process of activating helicopter EMS delays treatment for heart attacks beyond recommended times

STENTYS initiates international APPOSITION III self-apposing stent study in AMI patients

Everolimus plus tamoxifen delays disease progression in HR+/HER2- metastatic breast cancer

Children's Hospitals and Clinics of Minnesota installs Toshiba's Infinix CC-i system and MAQUET OR table

ART's stent superior than other bioresorbable stents

Sheathless transradial intervention highly successful in treating complex lesions

Cardiologists achieve 90% success rate in sheathless transradial PCI to remedy complex lesions

Report: Baltimore cardiologist inserted 'medically unnecessary' stents

Cardiologist provided unnecessary stent implants: investigation

FDA approves IDE application to initiate Tryton Side Branch Stent System for coronary artery disease

Cordis to distribute OSTIAL PRO Stent Positioning System worldwide

Interventional Radiology physician utilizes SUPERA VERITAS system to treat biliary stricture

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

Medtronic's implantable device delivers positive results for abdominal aortic aneurysms treatment

Boston Scientific signs definitive agreement to acquire Sadra Medical

Medtronic's Valiant Stent System effective for thoracic aortic aneurysms treatment

GRAVITAS Trial finds high dose of clopidogrel does not reduce risk of ischemic events

NTU to develop Five Peaks of Excellence under 5-year strategic plan

ESWL should be first choice for removing smaller kidney stones in distal ureter

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News